MIRABELLA FINANCIAL SERVICES LLP
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1538853
London, X0
Position in HRMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,129,219
-$2,118,092 QoQ
Shares Held
31,014
-73.2% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#136
of 328 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MIRABELLA FINANCIAL SERVICES LLP holds $3,358,382 across 9 Biotechnology names. HRMY ranks #1 (33.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
31,014 | $1,129,219 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
44,619 | $438,158 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
1,367 | $334,600 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,766 | $328,023 | |
| 5 | ABVX |
Abivax S.A.
|
2,337 | $311,428 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
3,009 | $261,632 | |
| 7 | INVA |
Innoviva, Inc.
|
10,744 | $243,996 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
30,093 | $170,928 |
All Filings in HRMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,129,219 | 31,014 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,247,311 | 115,934 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $498,658 | 13,326 | Shares | Sole | 2026-02-17 | |
| 2022-12-31 | $1,739,837 | 31,576 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,023,187 | 23,102 | Shares | Sole | 2022-10-28 | |
| 2021-12-31 | $1,581,219 | 37,083 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $482,464 | 14,232 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||